RESEARCH supported by a city university has found NO cervical cancer cases have been detected in fully vaccinated women since the HPV immunisation programme began in Scotland in 2008.

The exciting study from Public Health Scotland (PHS), in collaboration with the Universities of Strathclyde and Edinburgh, concludes the vaccine is highly effective in preventing the development of the disease.

The research is published in the Journal of the National Cancer Institute today (January 22), which also marks the start of Cervical Cancer Prevention Week.

The Glasgow Times is running a Don’t Fear the Smear campaign, which aims to encourage more women to attend their cervical screening appointment.

Glasgow Times: Don't Fear the Smear is a hardhitting Glasgow Times campaignDon't Fear the Smear is a hardhitting Glasgow Times campaign (Image: Newsquest)

HPV is a common virus, usually spread through sexual contact, and responsible for almost all cases of cervical cancer – the fourth-most common cause of cancer in women worldwide

The HPV vaccine is offered as a routine immunisation through school-based programmes to all S1 pupils in Scotland. It helps to protect both boys and girls from other HPV-related cancers later in life, such as head, neck and anogenital cancers as well as genital warts. 

This year’s HPV immunisation programme is already underway, with consent forms having been sent home from schools across most of Scotland. Young people are encouraged to talk to their parents or carers about the vaccine and return the signed consent forms by the deadline. 


READ NEXT: Glasgow film 'smashes myths' around HPV, cervical cancer and menopause


Dr Kirsty Roy, consultant in health protection at PHS, and co-author of the study, said: “This study involves every woman in Scotland who is eligible for the cervical cancer screening programme and demonstrates the impact of the HPV vaccine in preventing cervical cancer.

“It shows how effective the HPV vaccine is as there have been no cervical cancer cases to date in fully vaccinated women who were given their first dose at age 12 or 13 years.   

“Vaccination against HPV is shown to be effective in preventing cervical cancer, and along with regular screening for early detection and treatment, it is possible to make cervical cancer a rare disease.”

Dr Claire Cameron, consultant in health protection at PHS, said: “By continuing to vaccinate against HPV-related cancers, and encouraging uptake of screening, we hope to see them eliminated in the future.

“I would encourage all S1 pupils in Scotland to take up the offer of the free HPV vaccine in the coming months to protect themselves against future risks.”

Dr Tasmin Sommerfield, clinical advisor for screening at National Screening Oversight (NSO), said: “While the HPV vaccine protects against a lot of the different types of HPV virus that cause cancer, it can’t protect against them all and it’s still important that you go for regular cervical screening.

“Screening can find changes in the cells in your cervix even if you feel healthy and have no symptoms. If these are found at an early stage they are much easier to treat.”

Minister for Public Health Jenni Minto said: “The HPV vaccine programme is having a huge impact on preventing these cancers for those who have been vaccinated. Vaccination and screening remain the most effective ways of preventing and detecting cervical cancer and I would encourage those eligible to come forward to have the vaccine or attend screening appointments.”